Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct 29;22(1):43.
doi: 10.1186/s12979-025-00537-5.

Immune-mediated interactions between sarcopenia and atherosclerosis in aging

Affiliations
Review

Immune-mediated interactions between sarcopenia and atherosclerosis in aging

Mei Yu et al. Immun Ageing. .

Abstract

Sarcopenia and atherosclerosis are prevalent age-related conditions increasingly recognized as interconnected through shared immune-mediated pathways. This review elucidates how "inflammaging" driven by dysregulated immune responses. Key age-related mechanisms include macrophage polarization imbalance, T/B cell dysregulation, and activation of pro-inflammatory signaling pathways. These processes promote oxidative stress, insulin resistance, creating a vicious cycle that exacerbates muscle and vascular decline. Emerging therapeutic strategies offering potential for dual-benefit interventions. Understanding these immune interactions provides a foundation for integrated approaches to mitigate sarcopenia and atherosclerosis in aging.

Keywords: Aging; Atherosclerosis; Comorbidities; Inflammaging; Sarcopenia.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This review does not involve ethical approval. Consent for publication: All authors agree to publish this review. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Immune crosstalk between sarcopenia and atherosclerosis in aging, mainly mediated by inflammaging, macrophage and T cell, driving mutual decline via NLRP3, NF-κB, oxidative stress pathways

References

    1. Sayer AA, et al. Sarcopenia. Nat Rev Dis Primers. 2024;10(1):68. - PubMed
    1. Fantin F, et al. Central and peripheral arterial stiffness and sarcopenia in hospitalized older adults. Aging Clin Exp Res. 2025;37(1):223. - PMC - PubMed
    1. Khan A, Roy P, Ley K. Breaking tolerance: the autoimmune aspect of atherosclerosis. Nat Rev Immunol. 2024;24(9):670–9. - PMC - PubMed
    1. Cruz-Jentoft AJ, Sayer AA. Sarcopenia Lancet. 2019;393(10191):2636–46. - PubMed
    1. Chhetri JK, et al. Chronic inflammation and sarcopenia: a regenerative cell therapy perspective. Exp Gerontol. 2018;103:115–23. - PubMed

LinkOut - more resources